EnlitenAI is building an AI-powered clinical intelligence platform for neurological care. Device-agnostic, it integrates telemetry from wearables, implantables and ingestibles, along with real-world data to generate patient-specific insights that guide treatment optimization and titration. While initially focused on epilepsy, the platform is extensible across neurobehavioral disorders.

Headache Sciences is a clinical AI company developing EEG-based software to diagnose and monitor headache disorders. Our mission is to leverage our understanding of the electrical activity of the brain, and translate it into the tools practitioners need to improve the diagnostics, monitoring and treatment of headache related neurogenic and neurodegenerative disorders and diseases.

HumanNexus brings together neurotech innovators, investors, and commercialization partners in a cooperative venture ecosystem. Startups gain a faster path to market, partners gain steady work from motivated clients, and investors meet de-risked early-stage companies. Membership is free; fees begin only when tangible results are delivered.

Narbis makes Edge, smart glasses with patented electrochromic lenses that turn biofeedback into light. The lenses tint and clear in real time with the wearer's breathing, heart rhythm or brain activity, so people train while they read, work, play or practice their sport, with no screen to watch. Biofeedback is well established; the hard part is keeping people practicing, and feedback built into everyday life is our answer.Out of the box, Edge guides slow breathing on its own. With the Narbis app and a heart rate sensor, it finds each person's resonance breathing rate and tracks HRV training over time. Edge also works with BrainMaster, Thought Technology, NeuroGuide, Divergence Neuro and Muse, and our open SDK lets developers and research teams drive the lenses for their own protocols, from programmable visual occlusion to BCI training.Based in Bend, Oregon, with roots in NASA-based neurofeedback research. Edge is a general wellness product, not a medical device.

Neurogram has developed a hardware-agnostic, cloud-based solution that standardizes EEG data from various manufacturers, integrates with EMRs, significantly improves clinical workflows, and is accessible from any computer. With improved data security and the ability to analyze large datasets, this platform can support advances in biomarker development for neurological conditions and stimulate more clinical research and collaboration.

NOVA Biotech is a student-run biotech and entrepreneurship club at McGill University, under the Science Undergraduate Society. It connects McGill students with Montreal’s growing biotech ecosystem through three pillars: a speaker series with leaders in biotech, entrepreneurship and venture capital; an internship pipeline that screens and matches students with biotech and tech startups, backed by the NOVA Internship Fund for early-stage companies; and an annual Buildathon where students prototype and pitch biotech solutions. From January to May 2026, NOVA worked with 15+ companies, placed 10+ interns and raised $4,000+. Its goals for 2027 are 40+ interns, a $50,000+ fund and expansion across Canada.

Prescia Health Inc. is an early-stage Canadian digital health company developing MindMetrics, an innovative clinical decision-support platform at the intersection of gaming, computational neuroscience, artificial intelligence, and mental health.MindMetrics uses brief, engaging, gamified cognitive tasks to capture objective behavioural measures of decision-making, learning under uncertainty, stress reactivity, risk-taking, and social information processing. Through advanced computational modelling and hierarchical Bayesian approaches, these behavioural patterns are translated into interpretable brain-and-behaviour profiles that aim to provide deeper insights into underlying cognitive processes associated with psychosis risk and severe mental illness, including schizophrenia spectrum disorders.Designed to complement traditional psychiatric interviews, clinical assessments, and clinician judgment, MindMetrics aims to support more objective psychiatric triage, early identification of clinically relevant behavioural patterns, patient characterization, treatment monitoring, and personalized care planning. The platform is being developed for integration into existing healthcare workflows, with potential applications across psychiatric emergency departments, hospitals, outpatient clinics, and early psychosis intervention programs.Prescia Health was founded by Dr. Andreea Diaconescu, Scientist at the Krembil Centre for Neuroinformatics at CAMH and Associate Professor of Psychiatry at the University of Toronto, and is led by CEO Diya Shah, MHSc, with expertise in medical physiology, clinical research, neuroscience, and healthcare innovation.

Reccy Neuro was co-founded by Chay Carter, founder of Carter Sciences, host of The Open Loop podcast and author of The Neurotech Newsletter, and Max Kelly, founder of Arcane Intelligence. Max combines a background in life-sciences recruitment with hands-on experience building AI software and data infrastructure, alongside roles at Firecrawl and The Engine. Together, they’re building a more connected and accessible neurotech community.

The platform brings together more than 1,000 companies and 1,000 jobs globally, alongside industry news and events. Candidates can explore opportunities and learn more about the companies behind them. Employers can claim their company profile, keep their information current and reach people interested in working in neurotechnology.

Reccy also helps match candidates to roles and ranks applicants by fit, giving hiring teams a clearer starting point when reviewing applications. Thousands of candidates have accessed the platform since launch.

We're Synaptive, and we build the electrode that should have existed 100 years ago. Right now, if you've got curly, coily or afro-textured hair, you're systematically excluded from research and even worse, misdiagnosed in clinics. This is mostly because the electrodes built for neurotechnologies just don't work on these populations. We changed that. We built Syn-R1, an electrode that simply does work, for everyone. Check us out, and support us in building a better neurotech future.

VIBRAINT aims to fundamentally change the lives of 120 million paralyzed people  with a rehabilitation robot driven by AI-powered non-invasive brain-computer interface and featuring VR immersion, which 55,000 rehabilitation clinics in North America can introduce in one day and with $0 upfront cost.  

Our product addresses the critical gap in the standard of care for largely paralyzed patients - which is effectively zero. We aim bringing patients from zero limb mobility to the state where they can benefit form existing therapies, thus igniting their journey to recovery and self-sufficient lives.

Wavelet Medical is a non-invasive, AI-powered fetal electroencephalography (EEG) monitoring technology company. Using cutting-edge EEG technology and machine learning algorithms, our innovation delivers insights into fetal brain development, helping healthcare providers make informed decisions to eliminate preventable brain injuries and improve health outcomes.

WorldChangers is the first Brain-Computer Interface (BCI) startup accelerator in the US. Registered as non-profit. No equity taken. No strings attached